Child’s sudden death unnerves gene therapy field

The trial was a first test of viruses engineered to get past the blood-brain barrier.

December 15, 2025 Check out STAT+

Sponsored By

Maria Fabrizio for STAT STAT+ | Child's sudden death unnerves a promising area of gene therapy research Researchers fear a broad risk for any virus genetically designed to penetrate the blood-brain barrier after no hint of issues prior to Capsida trial death. By Jason Mast STAT+ | NIH specifies how grant reviewers should ensure alignment with Trump priorities In a memo obtained by STAT, the NIH gives specific steps on how grant reviewers can check for alignment with administration priorities. By Anil Oza STAT+ | The AI industry wants to turn the routine mammogram into a powerful multitool As AI adoption soars in radiology, artificial intelligence firms believe mammograms can be used to spot cardiovascular disease as well as breast cancer. By Katie Palmer Adobe Opinion: Siddhartha Mukherjee: Metabolism is the next frontier in cancer treatment It's time to move on from one-size-fits-all "cancer diets" and move instead to tumor-informed metabolism, writes Siddhartha Mukherjee. By Siddhartha Mukherjee Opinion: My patient was gone. I had to help his family see it Machines sustain the appearance of life, even when the person is already gone. I had to help my patient's family understand. By Raya Elfadel Kheirbek

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser